Tzu-Fei Wang: How Should We Approach Anticoagulation for Cancer-Associated Gonadal and Renal Vein Thrombosis?
Tzu-Fei Wang, Associate Professor at University of Ottawa, The Ottawa Hospital, and The Ottawa Hospital Research Institute, shared on LinkedIn about a recent article she and her colleagues co-authored, published in Thrombosis Research, adding:
“How should we approach anticoagulation in patients with cancer-associated gonadal and renal vein thrombosis?
These unusual-site venous thromboembolic events present important clinical challenges, and evidence to guide anticoagulation decisions and quantify the risks of recurrent VTE and bleeding remains limited.
Canada and Italy collaborations
N=138, 81.7% started on AC
6 and 12-mo recurrent VTE 3.8%, MB 2.5%”
Title: Anticoagulation management and outcomes in cancer-associated gonadal and renal vein thrombosis: A multicenter retrospective cohort study
Authors: Elena Butera, Chiara Cavallaro, Alessandro D’Errico, Rosa Talerico, Ranjeeta Mallick, Roger Kou, Marc Carrier, Roberto Pola, Tzu-Fei Wang
Stay updated on all scientific advances with Hemostasis Today.
-
Oct 10, 2026, 10:50Robert Sidonio Joins ATHN Advanced Clinical Research Fellowship Program
-
Oct 10, 2026, 10:45Federica Fogacci: Co-Moderating at CA Meet 2026 in Padua – Elevating Lifestyle Interventions in Cardiology
-
Oct 10, 2026, 10:40Juan Cristóbal Morales Muñoz: Pharmacokinetic Profiling of Factor VIII Concentrates in Chilean Patients
-
Oct 10, 2026, 10:32Randall Schaefer: What Do Blood Product Wastage Rates Really Tell Us in Prehospital Care?
-
Oct 10, 2026, 10:26Simone Strasser: ROTEM-Guided Transfusion Cuts Blood Product Use in Patients with Cirrhosis
-
Oct 10, 2026, 10:18Jérôme S.: WHO Launches Global Roadmap to Combat Hypertensive Disorders of Pregnancy
-
Oct 10, 2026, 10:07Maha Othman: Look Forward to an Amazing ISTH 2027 in Vancouver!
-
Oct 10, 2026, 10:02Rucha Patil: National Convening Highlights Opportunities for Equitable Hemophilia Care Across India
-
Oct 10, 2026, 09:52Yuria Ito: Should Ferritin Testing Become a Routine Part of Prenatal Care in Japan?